In its recent PEAK Matrix industry assessment report, Everest Group, one of the world’s leading consulting & research firm, has entitled Cognizant as one of the top providers of digital services for life sciences organizations. This is the first time Everest Group has assessed companies specializing in Life Sciences Digital Services across North America, comparing the capabilities of 23 service providers. Cognizant was highlighted in the report for having the largest market share and achieving top marks for its industry vision and capabilities.

“The North American life sciences industry is at an inflection point as it adopts digital technologies to make a conscious push towards precision medicine and other strategic bets.  Cognizant has capitalized on its life sciences pedigree to pursue partnerships and build capabilities that enable the digital journeys on which enterprises are embarking,” says Abhishek Singh, Practice Director, Everest Group.

Cognizant is at the forefront of helping biopharmaceutical and med-tech companies transform their businesses through end-to-end digital solutions that combine consulting, process operations and technology services. The company invests in products and common industry solutions such as Shared Investigator Platform, Smart Trials and Medvantage that are facilitating clients to accelerate this transformation more effectively and better compete in a complex and changing business environment.

“Life sciences companies are fundamentally reimagining their business models across the value chain to continue to advance science and improve patient lives. Our work with all of the leading life sciences companies highlights the dramatic digital shift taking place in the industry and we are appreciative of this recognition from Everest Group,” says Bhaskar Sambasivan, Senior VP & Global Market Leader, Cognizant’s Life Sciences business. 

Read more news:

COMPAREX Group: Navin Kapur appointed Executive Vice President of COMPAREX Asia